Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by canon12345on Jun 24, 2021 6:51am
266 Views
Post# 33440108

RE:RE:Covid mutation?

RE:RE:Covid mutation?Hey geric believe me I have zero faith in Don ever doing anything with this company. I wish i had never heard of RVX. The point is many different people are pointing out that covid is mutating and a strain could come along that the vaccines do not work against. The odds that RVX will have the drug of choice to battle this mutation are astronomical at best. Again I think all pharms need to keep working on their covid trials in case this mutation does occur. I have sold most of my position in rvx over the years and have incurred a substantial loss in the process. I continue to hold Zenith shares and assume Don will bungle this company away until it is worthless as well. It will take a minor miracle for most of us to ever recoup our losses from RVX/Zenith. 
<< Previous
Bullboard Posts
Next >>